Golden Seeds company NX Prenatal announced a new clinical study that demonstrates the company’s first-trimester pre-term birth test’s ability to predict the risk of spontaneous pre-term birth (sPTB) in nulliparous pregnant women. The study was published recently in the American Journal of Obstetrics and Gynecology. Read more here.